Company aims to improve health and quality of life for dialysis patients

For PR Web, click here

IRVINE, Calif. – May 31, 2022 – Healionics, a Tech Coast Angels’ portfolio company, was honored with the Angel Capital Association’s (ACA) highest honor: the 2022 Luis Villalobos Award. Named in memory of Tech Coast Angels’ (TCA) founder Luis Villalobos, the award recognizes the two most innovative and inspiring early-stage companies of the year – one each in Life Sciences and Technology. The award was presented at ACA’s Summit earlier this month.

Healionics’ STARgraft synthetic blood vessel is intended to provide a safer, more reliable way to access a patient’s bloodstream during dialysis, and the device is currently in clinical trials. TCA was introduced to Healionics through the Angel Syndication Network, and the company raised two rounds from TCA ACE funds.

“Working with TCA has been a great experience.  When we presented, it was clear from TCA members’ questions that they were familiar with the medical device industry and with typical issues facing early-stage companies,” said Mike Connolly, CEO of Healionics. “We were also impressed with the professionalism and speed of their diligence process and decision-making.”

“We are thrilled that ACA has once again recognized a TCA portfolio company for its highest honor. It’s an ongoing tribute to Luis Villalobos, who believed in new ideas that could make a powerful impact,” said Jeff Lapin, TCA chairman. “The work Healionics is doing may improve the lives of dialysis patients.”